Stock SILF HEMOGENYX PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Hemogenyx Pharmaceuticals Plc

Equities

SILF

GB00BYX3WZ24

Delayed London S.E.
Other stock markets
 11:35:27 2024-05-24 EDT 		5-day change 1st Jan Change
1.475 GBX -2.64% Intraday chart for Hemogenyx Pharmaceuticals Plc +1.03% -35.87%
04-25 EARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payout AN
04-25 Hemogenyx Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
HEMOGENYX PHARMACEUTICALS PLC Stock Hemogenyx Pharmaceuticals Plc
 25.28M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 23.4B -
ARGENX SE Stock argenx SE
 22.1B -
GENMAB A/S Stock Genmab A/S
 18.34B
  1. Stock Market
  2. Equities
  3. SILF Stock
  4. Charts Hemogenyx Pharmaceuticals Plc
  5. Sector Chart